1st Quarter - Report

WALGREEN COMPANY for WALGREEN COMPANY

Firm
Client
Income
—
Expenses
$300,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

Organized Retail Crime - as related to federalizing the crime - no specific legislation introduced

LobbyistCovered position, as disclosed
LESLIE HIGGINS —
SUSIE HOWARD —
HEATHER HERNDON SMITH —

Contacted: White House Office; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period

LobbyistCovered position, as disclosed
DEBBIE GARZA —
LESLIE HIGGINS —
SUSIE HOWARD —
BRYAN A SCHNEIDER —
HEATHER HERNDON SMITH —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2914 (110th)

Consumer Issues/Safety/Products CSP

S. 1276/H.R. 2747 the "Methamphetamine Production Prevention Act of 2007" - electronic logbooks, tracking systems; H.R. 3610 the "Food and Drug Import Safety Act of 2007" - Sec. 6 regarding country of origin labeling for drugs and devices; S. 2274 the "Dextromethrophan Abuse Reduction Act of 2007" - regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2045 the "Consumer Product Safety Commission Reform Act of 2007" - Sec. 23 (e) regarding the implementation of new lead standards; H.R. 1108 the "Family Smoking Prevention and Tobacco Control Act" Title I, Chapter IX Sec. 913 regarding equal treatment of retail outlets and Sec 917 regarding preservation of state and local authority.

LobbyistCovered position, as disclosed
LESLIE HIGGINS —
SUSIE HOWARD —
HEATHER HERNDON SMITH —

Contacted: White House Office; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1276 (110th), H.R. 3610 (110th), H.R. 1108 (110th), S. 2274 (110th), S. 2045 (110th), H.R. 2747 (110th)

Pharmacy PHA

S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet; S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation

LobbyistCovered position, as disclosed
DEBBIE GARZA —
LESLIE HIGGINS —
SUSIE HOWARD —
HEATHER HERNDON SMITH —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3700 (110th), H.R. 1956 (110th), S. 1145 (110th), S. 1951 (110th), H.R. 3580 (110th), H.R. 3140 (110th), H.R. 2900 (110th), H.R. 5629 (110th), H.R. 5491 (110th), S. 980 (110th), S. 2408 (110th), S. 1082 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.